Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.
about
The emerging role of FTY720 (Fingolimod) in cancer treatmentTetraspanins as therapeutic targets in hematological malignancy: a concise reviewNanopharmacology in translational hematology and oncologyMicrodomains in the membrane landscape shape antigen-presenting cell function.Anti-CD37 antibodies for chronic lymphocytic leukemia.Tumor antigen ROR1 targeted drug delivery mediated selective leukemic but not normal B-cell cytotoxicity in chronic lymphocytic leukemia.Drug-Free Macromolecular Therapeutics--A New Paradigm in Polymeric NanomedicinesNanotechnology applications in hematological malignancies (Review).Dual-functionalized liposomal delivery system for solid tumors based on RGD and a pH-responsive antimicrobial peptide.The preclinical discovery of rituximab for the treatment of non-Hodgkin's lymphoma.The antineoplastic properties of FTY720: evidence for the repurposing of fingolimod.Antibody-targeted biodegradable nanoparticles for cancer therapy.miR-181b as a therapeutic agent for chronic lymphocytic leukemia in the Eµ-TCL1 mouse model.A novel liposomal formulation of FTY720 (fingolimod) for promising enhanced targeted delivery.
P2860
Q26748927-A241EEB8-0DD9-451F-96D7-382531076005Q27002353-384AF446-CBBF-46EF-BBFD-90D965CE03FEQ33961538-62A5288C-7EC5-4AC4-B7CB-C49BD991DB0FQ34380974-45247D13-E404-4020-91AE-32FBDCEB638FQ34405641-F9C949EF-B35E-437D-94F7-BD951C63F617Q34747359-D2FB8D9B-AFB0-4169-8C19-73D5C71CCAFFQ35861726-E6BF93CA-8832-4F76-A0C2-D2E57ED1B27AQ35934466-A2E4C8D3-CCA8-443B-B6D1-51AB912EEF76Q36542204-885E9C62-E1AC-4FD9-8EEA-BF7A7C8C5849Q38530254-2F38374E-577E-438F-AED8-DB16CDC7DE9FQ38546700-B7A27EE1-8262-44A6-BB14-56BB867D2FECQ38665261-DFECBD0E-2255-46AA-A470-C8B9D3839840Q38862227-FA9DB0E1-4F3E-45C3-88EA-6C8C35D2594CQ39106527-6B155661-071E-4845-9D9F-B34B3BB91260
P2860
Targeted drug delivery and cross-linking induced apoptosis with anti-CD37 based dual-ligand immunoliposomes in B chronic lymphocytic leukemia cells.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 28 May 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Targeted drug delivery and cro ...... ic lymphocytic leukemia cells.
@en
Targeted drug delivery and cro ...... ic lymphocytic leukemia cells.
@nl
type
label
Targeted drug delivery and cro ...... ic lymphocytic leukemia cells.
@en
Targeted drug delivery and cro ...... ic lymphocytic leukemia cells.
@nl
prefLabel
Targeted drug delivery and cro ...... ic lymphocytic leukemia cells.
@en
Targeted drug delivery and cro ...... ic lymphocytic leukemia cells.
@nl
P2093
P2860
P921
P1433
P1476
Targeted drug delivery and cro ...... ic lymphocytic leukemia cells.
@en
P2093
Chaofang Yue
David Jarjoura
L James Lee
Michael E Paulaitis
Natarajan Muthusamy
Robert J Lee
Xiaokui Mo
Xinmei Wang
Yicheng Mao
P2860
P304
P356
10.1016/J.BIOMATERIALS.2013.04.063
P50
P577
2013-05-28T00:00:00Z